Calf Deep Vein Thrombosis Treatment Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a randomized double‐blind placebo controlled superiority clinical trial. Patients will be identified at the time of the diagnosis of acute calf deep vein thrombosis and approached at that time. If they agree they would be randomly assigned to placebo or apixaban treatment for three months. Along with this they will also undergo repeat ultrasounds at 7, 14, and 90 days along with telephone follow‐up at 30 and 60 days.
Epistemonikos ID: 393f35d2a86b36db718a9d27b62fbe2861944fa3
First added on: May 21, 2024